Skip to content

Effectiveness of a Transition Program for Adolescents With Congenital Heart Disease in the Transition to Adulthood

Effectiveness of a Transition Program to Empower Adolescents With Congenital Heart Disease in the Transition to Adulthood: the STEPSTONES Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02675361
Enrollment
189
Registered
2016-02-05
Start date
2016-07-01
Completion date
2021-06-30
Last updated
2021-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Keywords

Transfer to adult care, Continuity of patient care, Transition program

Brief summary

This study is part of a larger research project known as Swedish Transition Effects Project Supporting Teenagers with chrONic mEdical conditionS (STEPSTONES). This project was created to develop and evaluate transition programs in order to support adolescents with chronic conditions in Sweden. While STEPSTONES has a generic nature, the first transition program that will be evaluated targets adolescents with congenital heart disease (ConHD). This particular study involves a hybrid experimental design, meaning a randomized controlled trial is embedded in a longitudinal, observational study. This type of design will help to test the effectiveness of a transition program in order to empower adolescents with congenital heart disease in the transition to adulthood and check for potential contamination of the comparison group. We will recruit 210 participants: 140 adolescents will be part of the randomized controlled trial (70 in the intervention arm; 70 in the comparison arm), and 70 participants will be assigned to the observational, longitudinal arm of the study, which serves as control group in an intervention-naive center. Over a period of two years, three assessments will be done during which all participants will be asked to answer a set of questionnaires. The intervention to be tested involves patient empowerment, education on their ConHD, dealing with school, health behaviors required to maintain good health, guidance of parents, a person-centered transition plan, among others. The study hypothesis is that adolescents with ConHD who received a structured, person-centered transition program over a 2-year period have a higher patient empowerment score than adolescents who receive usual care.

Detailed description

Congenital heart diseases (ConHD) represent 28% of all congenital abnormalities.This population has experienced an increased life expectancy due to improvements in medical services and surgical techniques. Currently, around 90% of them will reach adulthood. Due to the complexity of these disorders, children with ConHD have to be under continuing follow-up. However, when they reach 18 years, they will be transferred to adult care. In order to help the adolescent in the transitions to adulthood and adult care, transitions programs have been proposed as a complex intervention with the objective of maximizing lifelong functioning and potential through appropriate healthcare services. Patient empowerment is recognized as an essential element of transition interventions.Through the promotion of patient empowerment the adolescents can become active partners in their care and have the knowledge and capacity to make decisions that affect their life and health status. While the importance of transition programs has been mentioned previously, high level evidence on the effectiveness of these interventions is limited. The purpose of this study is to assess the effectiveness of a transition program for adolescents with congenital heart disease. In order to asses the effectiveness of the transition program the investigators proposed a hybrid experimental design where a randomized controlled trial is embedded in a longitudinal, observational study. During the course of the study, participants will be part of a transition program or receive usual care before being transferred to adult care. The primary outcome is level of empowerment and secondary outcomes include patient-reported health, illness perception, quality of life, health behaviors, knowledge on congenital heart disease, transition readiness, parental uncertainty and parenting. The investigators will assess the effectiveness of the transition program by comparing the level of empowerment between the participants who received usual care and those who participated in the transition program. A higher level of empowerment from the group part of the intervention it's expected. A process and economic evaluation of the intervention will also be undertaken. The process evaluation will evaluate the process of care delivery within the transition program. This information will helped describe the mechanism of impact, explore potential expansion to other chronic conditions and to prepare permanent implementation of the transition program in Sweden. The economic evaluation entails an impact budget assessment and a cost-effectiveness analysis.

Interventions

Participants will be part of a transition program with eight key components: 1. A transition coordinator; 2. Education on congenital heart disease (CHD), treatments, health behavior, dealing with school, friends; 3. Telephone availability; 4. Information about the Grown-Up Congenital Heart Disease (GUCH) program: 5. Guidance of parents; 6. Meeting with peers: 7. A person-centered transition plan; and 8. Transfer to Grown-Up Congenital Heart Disease clinic. The intervention will be implemented by specialized nurses at the outpatient clinic of pediatric cardiology. Overall, 60 to 90 minutes per patient are spent over the 2.5 years.

Sponsors

Swedish Heart Lung Foundation
CollaboratorOTHER
Swedish Children Heart Association
CollaboratorUNKNOWN
The Swedish Research Council
CollaboratorOTHER_GOV
Sahlgrenska University Hospital
CollaboratorOTHER
Skane University Hospital
CollaboratorOTHER
Norrlands University Hospital
CollaboratorOTHER
Karolinska University Hospital
CollaboratorOTHER
Swedish Council for Working Life and Social Research
CollaboratorOTHER
Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Literate * Swedish-speaking * Diagnosed with a congenital heart disease * Age: 16 years

Exclusion criteria

* Syndromes affecting cognitive abilities * Acquired heart diseases * Heart transplantation

Design outcomes

Primary

MeasureTime frameDescription
Level of empowermentThree measurements over a 2-year period.Gothenburg Young Persons Empowerment Scale (GYPES) will be used to assess the level of empowerment. This scale was developed by the researchers involved in this study and has been tested in a previous cross sectional study in order to determine its psychometric properties in adolescents with congenital heart disease. The investigators will compare the level of empowerment between groups before and after the transfer of care. Empowerment level will be measured at three different points, when the participants are 16 (baseline), 17 (midterm) and 18 years old (after transfer).

Secondary

MeasureTime frameDescription
KnowledgeThree measurements over a 2-year period.Knowledge scale for adults with congenital malformed hearts
Health behaviorThree measurements over a 2-year period.Health behavior scale-congenital heart disease
Transition readinessThree measurements over a 2-year period.Readiness for transition questionnaire (adolescent version)
Patient reported health IThree measurements over a 2-year period.Questionnaire (PedsQL 4.0) (generic and cardiac module)
Patient reported health IIThree measurements over a 2-year period.Questionnaire (EQ-5D-3L)
Healthcare utilizationThree measurements over a 2-year period.Healthcare utilization questionnaire
Quality of lifeThree measurements over a 2-year period.Linear analog scale

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026